8 completed, 1 recruiting, 1 terminated. 7 Phase 4, 1 Not applicable, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 7 | Completed 6, Terminated 1 |
| Not applicable | 1 | Recruiting 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Atorvastatin (Lipitor): new trials by email Literature Review of Atorvastatin (Lipitor) trials Research Report on Atorvastatin (Lipitor)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Statin and Vitamin D Treatment in Patients With Thyroid Eye Disease Atorvastatin (Lipitor), Vitamin D - Thyroid Eye Disease, TED, Graves Ophthalmopathy | Not applicable | Recruiting | Taipei Veterans General Hospital, Taiwan | 120 | 2026-02-24 | 2026-04-30 |
| The Efficacy and Tolerability of Two Formulations of Atorvastatin In Korean Adult With Hypercholesterolemia Atorvastatin (Lipinon), Atorvastatin (Lipitor) - Dyslipidemia, Cardiovascular Disease | Phase 4 | Completed | Seoul National University Hospital | 289 | 2008-09-01 | 2013-12-17 |
| Efficacy of Actos Lipitor Pegasys & Ribavirin in CHC GT 1 Patients Who Relapsed or Nonresponded to Peg/Riba pioglitazone (Actos), atorvastatin (Lipitor) - Hepatitis c | Phase 4 | Completed | Brooke Army Medical Center | 20 | 2008-09-01 | 2012-02-14 |
| Dyslipidemia in Cardiovascular Disease Atorvastatin (Lipilou), Atorvastatin (Lipitor) - Dyslipidemia | Phase 4 | Completed | Chong Kun Dang Pharmaceutical | 244 | 2008-08-01 | 2012-08-09 |
| Use of Atorvastatin (Lipitor) to Decrease Panel Reactive Antibody Titers Atorvastatin (Lipitor) - End-Stage Kidney Disease | Phase 1 | Completed | University of Chicago | 20 | 2005-05-01 | 2013-01-10 |
| Association Between Systemic Exposure of Atorvastatin and Metabolites and Atorvastatin-induced Myotoxicity Atorvastatin (Lipitor) - Myopathy | Phase 4 | Completed | University of Oslo School of Pharmacy | 2005-02-01 | 2014-12-03 | |
| High-Density Lipoprotein (HDL) Cholesterol Increased Plaque Stabilization in the Elderly any statin, niacin, Placebo - Atherosclerosis, Cardiovascular Disease | Phase 3 | Completed | Johns Hopkins University | 145 | 2003-09-01 | 2017-11-06 |
| Establish The Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets (ACTFAST) Atorvastatin (Lipitor) - Coronary Arteriosclerosis, Diabetes Mellitus, Type 2 | Phase 4 | Completed | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2080 | 2003-01-01 | 2021-02-18 |
| Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets Atorvastatin (Lipitor) - Coronary Arteriosclerosis, Diabetes Mellitus, Type 2 | Phase 4 | Completed | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 595 | 2003-01-01 | 2021-02-18 |
| The Effect of Lipitor on Aortic Stenosis atorvastatin (Lipitor) - Aortic Valve Stenosis | Phase 4 | Terminated | The Cleveland Clinic | 59 | 2000-08-01 | 2017-07-26 |
Dyslipidemias (4) · Cardiovascular Diseases (2) · Coronary Artery Disease (2) · Diabetes Mellitus, Type 2 (2) · Peripheral Vascular Diseases (2) · Stroke (2) · Aortic Valve Stenosis (1) · Atherosclerosis (1) · Autoimmune Diseases (1) · Graves Ophthalmopathy (1) · Hepatitis C (1) · Hypercholesterolemia (1) · Inflammation (1) · Kidney Diseases (1) · Kidney Failure, Chronic (1)
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (2) · Brooke Army Medical Center (1) · Chong Kun Dang Pharmaceutical (1) · Johns Hopkins University (1) · Seoul National University Hospital (1) · Taipei Veterans General Hospital, Taiwan (1) · The Cleveland Clinic (1) · University of Chicago (1) · University of Oslo School of Pharmacy (1)
United States (4) · Cameroon (1) · Canada (1) · Greece (1) · Hungary (1) · Ireland (1) · Italy (1) · Poland (1) · Portugal (1) · Russia (1) · Slovakia (1) · South Korea (1) · Spain (1) · Switzerland (1) · Taiwan (1)
Brian P Griffin, M.D. (1) · Chin-Sung Kuo, MD, PhD (1) · Joao AC Lima, MD, MBA (1) · Pradeep Kadambi, MD (1) · Stephen A Harrison, MD (1)
PMID 17626713, PMID 19217176, PMID 21610204, PMID 23274145
R01AG021570 (1)